Aeolus Pharmaceuticals Inc. filed its 10-K on Dec 22, 2014 for the period ending Sep 30, 2014. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 152 | |
+2.54% | 42.75B | |
+47.70% | 41.61B | |
+12.30% | 41.34B | |
-8.83% | 26.59B | |
+8.11% | 25.49B | |
-22.47% | 18.12B | |
+30.86% | 12.24B | |
-1.60% | 11.76B | |
+9.29% | 11B |
- Stock Market
- Equities
- AOLS Stock
- News Aeolus Pharmaceuticals, Inc.
- Aeolus Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt